Japan’s drug pricing panel held its final round of industry hearings on December 10 as it heads toward the FY2026…
HOME > ARCHIVE
ARCHIVE
- WORLD NEWS ON BRIEF
May 21, 2001
- Sankyo Stresses Fewer Drug Interactions for Mevalotin
May 21, 2001
- Sanofi-Synthelabo, Organon to Jointly Start PII for Pentasaccharide
May 21, 2001
- Daiichi Applies for Chronic Heart Failure as New Indication for Carvedilol
May 21, 2001
- Nippon BD to Open Lab in Advanced Medical Center in Kobe
May 21, 2001
- Dainippon Licenses Antipsychotic Blonanserin to Almirall
May 21, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
May 21, 2001
- BUSINESS NEWS IN BRIEF -1-
May 21, 2001
- PAJ New Chairman to Be Enthusiastic about Promoting Self-medication
May 21, 2001
- BUSINESS NEWS IN BRIEF -2-
May 21, 2001
- Kawachi Yakuhin Ties Up with Sun Drug
May 21, 2001
- NBI to Increase Its Sales to \110 Bil. in 2004: President Kawabata
May 14, 2001
- GLs on Proper Use of Antibacterials Completed
May 14, 2001
- Eisai Ties Up with Neurogenetics
May 14, 2001
- OTC NEWS IN BRIEF
May 14, 2001
- BUSINESS NEWS IN BRIEF -1-
May 14, 2001
- Sumitomo Corp. Establishes Bioventure Investment Fund
May 14, 2001
- DIAGNOSTIC NEWS IN BRIEF
May 14, 2001
- Rohto to Launch Obagi Series of Skin Care Products in Japan
May 14, 2001
- MEDICAL DEVICE NEWS IN BRIEF
May 14, 2001
ページ
Japan has presented its latest draft policy direction for its FY2026 drug pricing reform. While the package includes a string…
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…